User:Mr. Ibrahem/Omadacycline

Omadacycline, sold under the brand name Nuzyra, is an antibiotic used to treat community-acquired pneumonia and skin and skin structure infections. It is taken by mouth or by injection into a vein.

Common side effects include liver problems, high blood pressure, trouble sleeping, diarrhea, and headache. Other side effects may include allergic reactions, tooth discoloration when used in those under 8 years old, and Clostridioides difficile infection. It is a tetracycline antibiotics in the aminomethylcycline subclass.

Omadacycline was approved for medical use in the United States in 2018. It is not approved in either the United Kingdom or Europe as of 2021. In the United States 14 days of treatment costs about 7,100 USD as of 2021.